SCHEMBL168202

SCHEMBL168202

COc1c[nH]nc1C(=O)Nc1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
ATM Q13315 1/20 0.49
KMT2A Q03164 5/20 0.48
MEN1 O00255 4/20 0.48
ALDH1A1 P00352 2/20 0.48
MAPT P10636 4/20 0.47
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KDM4E B2RXH2 1/20 0.45
CXCR1 P25024 1/20 0.44
CXCR2 P25025 1/20 0.44
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167754 0.86 KMT2A (0.46) NPC1RAB9AATMKMT2AMEN1
SCHEMBL164283 0.85 ALDH1A1 (0.49) NPC1RAB9AATMKMT2AMEN1
SCHEMBL8221792 0.82 RAB9A (0.51) RAB9AMAPTTP53POLBSMN1; SMN2
SCHEMBL956847 0.81 MAPT (0.53) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL953001 0.80 JAK2 (0.45) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL953263 0.79 CDK2 (0.54) NPC1RAB9AATMKMT2AMEN1
SCHEMBL956114 0.79 CCNA2 (0.56) NPC1RAB9AATMKMT2AMEN1
SCHEMBL4564408 0.77 ALDH1A1 (0.47) NPC1RAB9AATMKMT2AMEN1
SCHEMBL954483 0.77 KMT2A (0.45) NPC1RAB9AATMKMT2AMEN1
SCHEMBL955330 0.76 PTPN1 (0.56) NPC1RAB9AATMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609091-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS Lead Discovery Center GmbH (DE) 2013-07-03 EP disclosed
WO-2012028332-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2012-03-08 WO disclosed